Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot open-label study of Normosang in patients with COVID-19
2020-004682-39Phase 4Terminated
- Sponsor
- Thomayer University Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of heme arginate in coronavirus disease 2019 (COVID-19), sponsored by Thomayer University Hospital. Primary endpoint: Primary: confirmation of safety of the drug. Started Nov 2020; status: terminated.
02
Drugs
heme arginate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-004682-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004682-39.